Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor
S. Pastore et al., Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor, J INVES DER, 115(6), 2000, pp. 1134-1143
Keratinocytes of patients with atopic dermatitis produce high amounts of gr
anulecyte/macrophage colony-stimulating factor, a factor essential for dend
ritic cell function and thus for the development of skin immune responses.
In contrast to keratinocytes cultured from nonatopic, healthy individuals,
granulocyte/macrophage colony-stimulating factor mRNA could be detected in
unstimulated cultures of atopic dermatitis keratinocytes, and phorbol myris
tate acetate induced much greater granulocyte/macrophage colony-stimulating
factor mRNA levels in these cells, although the decay kinetics were not al
tered. Using reporter gene (chloramphenicol acetyl transferase) analysis, a
minimal granulocyte/macrophage colony-stimulating factor promoter was show
n to confer constitutive and phorbol-myristate-acetate-induced regulation o
f transcriptional activity in keratinocytes, and significantly higher level
s of chloramphenicol acetyl transferase activity were measured in lysates o
f unstimulated and phorbol-myristate-acetate-treated atopic dermatitis kera
tinocytes than in control keratinocyte cultures. Electrophoretic mobility s
hift assays showed that low levels of NF-kappaB binding activity could be i
nduced by phorbol myristate acetate in both normal and atopic dermatitis ke
ratinocytes. By contrast, activator protein 1 complexes were efficiently in
duced, and they were invariably present at higher levels in nuclear lysates
of atopic dermatitis keratinocytes. Atopic dermatitis keratinocyte nuclear
lysates had higher constitutive levels of c-Jun, and phorbol myristate ace
tate promoted an earlier and stronger expression of c-Jun, JunB, and of the
phosphorylated forms of c-Fos. A dysregulated activation of activator prot
ein 1 may be implicated in the molecular mechanisms leading to increased gr
anulecyte/macrophage colony-stimulating factor expression in atopic dermati
tis keratinocytes.